Nezelof C, Frileux-Herbet F, Cronier-Sachot J
Cancer. 1979 Nov;44(5):1824-38. doi: 10.1002/1097-0142(197911)44:5<1824::aid-cncr2820440542>3.0.co;2-j.
This work is a retrospective study of 50 cases of DHX, collected over a period of 27 years. 24 children died, 26 are still alive. The prognosis for DHX was neither dependent on age (usually occurring in children under 2 years) nor on histological findings but on the extent of the lesions. It was possible to establish a clinical staging system distinguishing 2 groups. One, where the disease was severe and almost always fatal, often included the combined symptoms of thrombocytopenia, spontaneous anemia, jaundice, hepatosplenomegaly, respiratory insufficiency and absence of osteolytic lesions. The other, with a favorable prognosis, was characterized by skin lesions, diabetes insipidus, exclusively radiological pulmonary involvement and multiple bone lesions. In cases where death did not occur, DHX was often chronic, frequently persisting for 2 years or more and leading to serious sequelae such as diabetes insipidus, growth stunting, intellectual retardation, blindness or deafness.
这项工作是对50例弥漫性组织细胞增生症(DHX)进行的回顾性研究,收集时间跨度为27年。24名儿童死亡,26名仍然存活。DHX的预后既不取决于年龄(通常发生在2岁以下儿童),也不取决于组织学检查结果,而是取决于病变范围。有可能建立一个区分两组的临床分期系统。一组病情严重且几乎总是致命的,通常包括血小板减少、自发性贫血、黄疸、肝脾肿大、呼吸功能不全和无溶骨性病变等综合症状。另一组预后良好,其特征为皮肤病变、尿崩症、仅为放射学检查显示的肺部受累以及多发骨病变。在未发生死亡的病例中,DHX往往呈慢性,经常持续2年或更长时间,并导致诸如尿崩症、生长发育迟缓、智力迟钝、失明或失聪等严重后遗症。